A protein that impacts Alzheimer’s disease offers new opportunities for targeted treatments, although its cell-specific ...

A comprehensive Thought Leaders Invited Review in Brain Medicine highlights the crucial role of CD2-associated protein (CD2AP ...

The build-up of proteins associated with Alzheimer's were reduced by a plant compound which also lowered inflammation and ...

diseases driven by synapse loss and dysfunction. Boost Neuroscience was spun out of the Stanford University lab of Dr. Thomas Südhof, MD. Dr. Südhof was awarded the 2013 Nobel Prize in ...

Toxic Lipid Secretion: The ISR pathway in microglia was shown to drive the synthesis and release of harmful lipids that contribute to synapse loss, a hallmark of Alzheimer's disease. Therapeutic ...

Noise exposure is one of the most significant causes of synapse loss between inner hair cells and auditory nerve fibers, leading to a decline in hearing sensitivity.

His team has begun experiments to test if the stimulatory impact of psychedelics on peripheral synapse formation has therapeutic potential to treat disorders such as hearing loss and neuropathies.

systemic inflammation and virus-sensing pattern recognition receptors. Microglial dysfunction occurs at sites of vascular inflammation with myelin injury and synapse loss.

A new study has found that a compound that is derived from herbs - such as rosemary and sage - can help to reverse some of ...